Oxford begins trial of Ebola vaccine that works JUST like Covid jab
New Ebola vaccine made by team behind Oxford/AstraZeneca Covid vaccine starts human trials 26 people are taking part in the …
Home »
New York takes Teva, McKesson, others to trial over opioids
NEW YORK (Reuters) – New York will take Teva Pharmaceutical Industries and other companies, including the nation’s largest drug distributors, …
U.S. clinical trial results show Novavax vaccine is safe and prevents COVID-19
Results from a Phase 3 clinical trial enrolling 29,960 adult volunteers in the United States and Mexico show that the …
Moderna’s Vaccine Trial Results For Teens Mean Good News For Parents
Amid the news that adolescents may be able to begin getting COVID-19 vaccines made by Pfizer as early as next …
Trial tests intervention to reduce sedentary time in patients with kidney disease
A recent randomized trial tested an intervention to reduce sedentary time and increase physical activity in individuals with kidney disease. …
Results of ACTIV-3 trial published: Experimental monoclonal antibody not efficacious in Phase 3 trial
Preliminary results of a phase 3, randomized, placebo-controlled clinical trial testing the investigative monoclonal antibody LY-CoV555 in hospitalized COVID-19 patients …
Largest clinical trial in Africa to treat mild COVID-19 cases launched in 13 countries
Thirteen African countries and an international network of research institutions have joined forces to launch the largest COVID-19 clinical trial …
AstraZeneca Releases COVID-19 Vaccine Trial Plans
MONDAY, Sept. 21, 2020 — AstraZeneca is the latest drug company to release details about human tests of its COVID-19 …
Preserved heart failure trial misses endpoint, but drug may benefit some patients
The number of patients with heart failure with preserved ejection fraction is on the rise, and the search is on …
Favorable outcomes seen in long term for ALLR3 trial
(HealthDay)—For children with B-cell precursor acute lymphoblastic leukemia with late bone marrow relapse, risk stratification by minimal residual disease seems …
Phase 2 Clinical Trial of Bermekimab Shows Potential New Standard of Care for Treatment of Hidradenitis Suppurativa, Including Significant Pain Reduction without Antibiotics
AUSTIN, Texas, March 05, 2019 (GLOBE NEWSWIRE) — XBiotech (NASDAQ: XBIT) today released findings for its Phase 2 clinical study …
MediciNova Announces Initiation of Enrollment in a Clinical Trial of MN-166 (ibudilast) in Glioblastoma
LA JOLLA, Calif., Jan. 08, 2019 (GLOBE NEWSWIRE) — MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market …